TherapeuticsMD, Inc. Retained Earnings
TherapeuticsMD, Inc. (TXMD) had Retained Earnings of -$952.14 million as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-08-11
- 2026-06-30: Retained Earnings (Accumulated Deficit) -$952.14M.
- 2026-03-31: Retained Earnings (Accumulated Deficit) -$952.30M.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$952.39M.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$951.77M.
| Period end | Retained Earnings (Accumulated Deficit) | Retained Earnings (Accumulated Deficit) as first filed |
|---|---|---|
| 2026-06-30 | -$952.14M 10-Q · filed 2026-08-11 | |
| 2026-03-31 | -$952.30M 10-Q · filed 2026-05-12 | |
| 2025-12-31 | -$952.39M 10-Q · filed 2026-08-11 | |
| 2025-09-30 | -$951.77M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | -$951.92M 10-Q · filed 2025-08-12 | |
| 2025-03-31 | -$952.48M 10-Q · filed 2025-05-13 | |
| 2024-12-31 | -$951.82M 10-K/A · filed 2026-04-01 | |
| 2024-06-30 | -$951.47M 10-Q · filed 2024-08-12 | |
| 2023-12-31 | -$949.64M 10-K · filed 2025-03-27 | |
| 2023-09-30 | -$948.76M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | -$945.38M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | -$942.97M 10-Q · filed 2023-05-15 | |
| 2022-12-31 | -$939.36M 10-K · filed 2024-03-29 | |
| 2022-09-30 | -$1.02B 10-Q · filed 2022-11-14 | |
| 2022-06-30 | -$988.10M 10-Q · filed 2022-08-15 | |
| 2022-03-31 | -$1.10B 10-Q · filed 2022-05-16 | |
| 2021-12-31 | -$1.05B 10-K · filed 2023-04-07 | |
| 2021-09-30 | -$1.01B 10-Q · filed 2021-11-12 | |
| 2021-06-30 | -$960.98M 10-Q · filed 2021-08-04 | |
| 2021-03-31 | -$918.33M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | -$878.95M 10-K · filed 2022-03-23 | -$878.95M 10-K · filed 2021-03-04 |
| 2020-09-30 | -$836.86M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | -$804.25M 10-Q · filed 2020-08-07 | |
| 2020-03-31 | -$752.27M 10-Q · filed 2020-05-06 | |
| 2019-12-31 | -$695.42M 10-K · filed 2021-03-04 | |
| 2019-09-30 | -$645.99M 10-Q · filed 2019-11-08 | |
| 2019-06-30 | -$614.02M 10-Q · filed 2019-08-09 | |
| 2019-03-31 | -$558.78M 10-Q · filed 2019-05-08 | |
| 2018-12-31 | -$519.28M 10-K · filed 2020-02-24 | |
| 2018-09-30 | -$479.89M 10-Q · filed 2018-11-08 | |
| 2018-06-30 | -$444.28M 10-Q · filed 2018-07-30 | |
| 2018-03-31 | -$411.06M 10-Q · filed 2018-05-07 | |
| 2017-12-31 | -$386.66M 10-K · filed 2019-02-27 | |
| 2017-09-30 | -$365.23M 10-Q · filed 2017-11-07 | |
| 2017-06-30 | -$350.57M 10-Q · filed 2017-08-03 | |
| 2017-03-31 | -$330.89M 10-Q · filed 2017-05-03 | |
| 2016-12-31 | -$309.70M 10-K · filed 2018-02-23 | |
| 2016-09-30 | -$286.87M 10-Q · filed 2016-11-04 | |
| 2016-06-30 | -$261.85M 10-Q · filed 2016-08-05 | |
| 2016-03-31 | -$240.76M 10-Q · filed 2016-05-05 | |
| 2015-12-31 | -$219.83M 10-K · filed 2017-02-28 | |
| 2015-09-30 | -$202.34M 10-Q · filed 2015-11-05 | |
| 2015-06-30 | -$182.87M 10-Q · filed 2015-08-07 | |
| 2015-03-31 | -$155.64M 10-Q · filed 2015-05-07 | |
| 2014-12-31 | -$134.75M 10-K · filed 2016-02-26 | |
| 2014-09-30 | -$118.45M 10-Q · filed 2014-11-07 | |
| 2014-06-30 | -$100.62M 10-Q · filed 2014-08-07 | |
| 2014-03-31 | -$89.72M 10-Q · filed 2014-05-07 | |
| 2013-12-31 | -$80.53M 10-K · filed 2015-03-12 | |
| 2013-09-30 | -$72.15M 10-Q · filed 2013-11-05 | |
| 2013-06-30 | -$64.50M 10-Q · filed 2013-08-07 | |
| 2013-03-31 | -$58.49M 10-Q · filed 2013-05-10 | |
| 2012-12-31 | -$52.11M 10-K · filed 2014-03-05 | |
| 2012-09-30 | -$46.39M 10-Q · filed 2012-11-13 | |
| 2012-06-30 | -$42.13M 10-Q · filed 2012-08-09 | |
| 2012-03-31 | -$30.28M 10-Q · filed 2012-05-11 | |
| 2011-12-31 | -$16.99M 10-K · filed 2013-03-12 | |
| 2011-09-30 | -$2.11M 10-Q · filed 2011-11-07 | |
| 2011-06-30 | -$2.03M 10-Q · filed 2011-08-15 | |
| 2010-12-31 | -$2.59M 10-Q · filed 2011-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |